Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Abstract Background There is no consensus on the optimal initial treatment for polypoidal choroidal vasculopathy (PCV). Our study aimed to report the efficacy of repeated injections of intravitreal ranibizumab with or without photodynamic therapy for the treatment of PCV and to determine the possibl...
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
BMC
2019-07-01
|
| Σειρά: | BMC Ophthalmology |
| Θέματα: | |
| Διαθέσιμο Online: | http://link.springer.com/article/10.1186/s12886-019-1156-4 |